| Quarterly Financials | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 832 | 888 | 901 | 998 | 994 | 1,043 | 1,111 | 1,312 | 1,367 | 1,346 | 1,410 | 1,576 | 1,711 | 1,914 |
| Expenses | 810 | 867 | 873 | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,647 | 1,824 |
| EBITDA | 21 | 21 | 27 | 31 | 30 | 38 | 44 | 54 | 58 | 56 | 56 | 67 | 64 | 90 |
| Operating Profit % | 2 % | 2 % | 3 % | 3 % | 3 % | 3 % | 3 % | 3 % | 4 % | 4 % | 4 % | 4 % | 3 % | 5 % |
| Depreciation | 5 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 10 | 15 |
| Interest | 13 | 13 | 14 | 18 | 16 | 17 | 10 | 12 | 10 | 11 | 11 | 12 | 14 | 17 |
| Profit Before Tax | 3 | 1 | 7 | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 |
| Tax | -1 | 5 | 0 | 2 | 1 | -8 | 7 | 9 | 10 | 6 | 6 | 8 | 7 | 13 |
| Net Profit | 4 | -4 | 6 | 5 | 7 | 21 | 21 | 26 | 30 | 31 | 30 | 37 | 34 | 45 |
| EPS in ₹ | 8.67 | 1.49 | 15.18 | 3.24 | 4.21 | 5.73 | 4.62 | 5.43 | 5.85 | 5.91 | 6.39 | 7.26 | 6.35 | 6.44 |
Entero Healthcare Solutions
Entero Healthcare Solutions
1,089.40
-16.10
(-1.46%)
Market Cap
4,740.08 Cr
PE Ratio
32.99
Volume
1,12,161.00
Day High - Low
1,117.70 - 1,085.00
52W High-Low
1,390.00 - 944.00
Key Fundamentals
Market Cap
4,740.08 Cr
EPS
26.44
PE Ratio
32.99
PB Ratio
2.85
Book Value
388.00
EBITDA
257.77
Dividend Yield
0.00 %
Industry
Retail Sector
Pharmacy Retail Return on Equity
6.07
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Entero Healthcare director resigns
8 days ago
8 days agoKevin Rohitbhai Daftary resigns as Nominee Director from Entero Healthcare Solutions effective June 12, 2026, citing increased professional commitments.
Promoter declares no encumbrance on sharesJun 06, 2026
Jun 06, 2026Prem Sethi declared no encumbrance on shares for FY26. The filing was made to BSE and NSE on April 06, 2026.
Entero Healthcare Q4FY26 earnings call on May 26May 21, 2026
May 21, 2026Entero Healthcare Solutions Limited will hold an earnings call for Q4FY26 on May 26, 2026, at 12:00 pm IST. Management will discuss audited financial results for the quarter and year ended March 31, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
844.45 | #1 10,138.01 | 46.58 | #1 6,892.47 | 11.44 | #1 198 | 24.76 | 40.40 | |
1,089.40 | #2 4,740.08 | #1 32.99 | #2 6,591.21 | #1 28.35 | #2 120 | #1 43.63 | 37.07 | |
75.82 | 181.17 | - | 9.20 | -4.17 | -2 | -166.67 | 60.34 | |
85.95 | 167.85 | 33.03 | 98.96 | -16.06 | 5 | - | 49.13 |
Growth Rate
Revenue Growth
28.35 %
Net Income Growth
11.60 %
Cash Flow Change
-109.97 %
ROE
150.83 %
ROCE
67.13 %
EBITDA Margin (Avg.)
-5.11 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 | 3,600 |
| Fixed Assets | 186 | 189 | 262 | 268 | 289 | 559 | 211 |
| Current Assets | 552 | 636 | 851 | 1,023 | 2,011 | 2,076 | 2,508 |
| Capital Work in Progress | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 | 842 |
| Other Assets | 561 | 645 | 863 | 1,041 | 2,056 | 2,085 | 0 |
| Total Equity & Liabilities | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 | 3,600 |
| Current Liabilities | 269 | 291 | 462 | 624 | 602 | 845 | 1,588 |
| Non Current Liabilities | 56 | 58 | 101 | 87 | 102 | 87 | 260 |
| Total Equity | 424 | 487 | 563 | 598 | 1,641 | 1,770 | 1,689 |
| Reserve & Surplus | -16 | -32 | -62 | -73 | 1,593 | 1,676 | 1,645 |
| Share Capital | 439 | 517 | 4 | 4 | 44 | 44 | 44 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 | 82 |
| Investing Activities | -203 | -31 | -162 | -49 | -704 | 232 |
| Operating Activities | -37 | -69 | -35 | -45 | -37 | -77 |
| Financing Activities | 217 | 89 | 211 | 73 | 863 | -74 |
Share Holding
| % Holding | Sept 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 78.85 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.42 % | 52.42 % | 52.42 % | 52.42 % | 52.42 % |
| FIIs | 0.00 % | 0.00 % | 23.30 % | 23.32 % | 23.82 % | 22.21 % | 19.92 % | 17.20 % | 14.67 % | 5.14 % | 4.03 % |
| DIIs | 0.00 % | 1.36 % | 2.28 % | 2.06 % | 7.73 % | 8.77 % | 9.64 % | 10.18 % | 9.65 % | 16.42 % | 16.62 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.72 % | 4.95 % | 5.00 % | 4.06 % | 4.36 % | 5.41 % | 6.99 % | 9.36 % | 11.56 % | 12.25 % |
| Others | 21.15 % | 40.48 % | 17.03 % | 17.18 % | 11.95 % | 12.23 % | 12.61 % | 13.20 % | 13.90 % | 14.46 % | 14.68 % |
| No of Share Holders | 51 | 58 | 80,864 | 66,400 | 36,767 | 33,172 | 33,159 | 33,338 | 36,334 | 40,332 | 39,083 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 19 Aug 2026 |  Annual General Meeting | NA | 19 Aug 2026 | 1,354.40 | 1,091.85 |
| 28 Aug 2024 | Annual General Meeting | NA | 28 Aug 2024 | 1,245.00 | 1,301.20 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 1,387.70 | 1,477.80 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,372.25 | 1,328.65 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 1,443.60 | 1,477.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 1,265.95 | 1,257.25 |
| 18 Sept 2025 | Annual General Meeting | NA | 18 Sept 2025 | 1,158.70 | 1,132.30 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 1,111.35 | 1,089.00 |
| 12 Feb 2026 | Quarterly Result Announcement | NA | 12 Feb 2026 | 1,131.80 | 1,148.70 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 1,192.80 | 1,354.40 |
Announcements
Announcement under Regulation 30 (LODR)-Resignation of Director8 days ago
8 days agoThe Grant Of Fresh 17500 (Seventeen Thousand Five Hundred) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023.9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS9 days ago
9 days agoBoard Meeting Outcome for Outcome Of Board Meeting9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2026
Jun 02, 2026Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026May 28, 2026
May 28, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 25, 2026
May 25, 2026The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP (EY) For The Next Financial Year 2026-27.May 25, 2026
May 25, 2026The Grant Of Fresh 7300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023.May 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-AcquisitionMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-AllotmentMay 25, 2026
May 25, 2026Board Meeting Outcome for Outcome Of Board Meeting May 25 2026May 25, 2026
May 25, 2026Results - Financial Year 2025-26May 25, 2026
May 25, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2026
May 21, 2026Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements For The Quarter And Year Ended March 31 2026.May 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementMay 06, 2026
May 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 11, 2026
Mar 11, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2026
Mar 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2026
Mar 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2026
Feb 26, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Feb 20, 2026Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 With UDINFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Feb 12, 2026Intimation For Grant Of Fresh 5000 ESOPFeb 12, 2026
Feb 12, 2026Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Feb 12, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On February 12 2026Feb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Feb 09, 2026Update On AcquisitionFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Feb 06, 2026Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended December 31 2025Feb 03, 2026
Feb 03, 2026Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015.Jan 27, 2026
Jan 27, 2026Change Of Name Of M/S. M S K A & Associates Chartered Accountants Statutory Auditor Of The Company - Upon Conversion Of Firm Into LLPJan 15, 2026
Jan 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 23, 2025
Dec 23, 2025Intimation For Grant Of 73060Options Pursuant To "Entero Employees Stock Options Plan 2023" To The Eligible Employees Of The CompanyDec 06, 2025
Dec 06, 2025Announcement under Regulation 30 (LODR)-Credit RatingDec 04, 2025
Dec 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Nov 27, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 37.07
ATR(14)
Less Volatile 46.58
STOCH(9,6)
Oversold 15.77
STOCH RSI(14)
Oversold 14.94
MACD(12,26)
Bearish -4.89
ADX(14)
Weak Trend 10.30
UO(9)
Bearish 33.36
ROC(12)
Downtrend And Accelerating -3.37
WillR(14)
Oversold -96.17
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
